A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes

Overview of attention for article published in Lipids in Health and Disease, April 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 112 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 98,588 followers.

@DoctorTro @erreyedoc @Drlipid @jlevallois @BravuraGeorgio @Lpa_Doc @DrNadolsky @BrianLenzkes 1/ #SGLTL2 ref: https://t.co/3UcPBKRLSC https://t.co/S8fOVtjTlC

03 Apr 2021

Reply Repost Favourite

But remember, low carb diets are dangerous because they (might) raise LDL... 🤔 “The SGLT2 inhibitor was associated with a significant increase in HDL-C and LDL-C after 24 weeks of SGLT2 inhibitor treatment in patients with type 2 diabetes....” https://t.

02 Sep 2020

Reply Repost Favourite

@DaveKeto https://t.co/OlVgBCTUa8 https://t.co/RduD2CKBsq https://t.co/axa5Y4s47n

05 Aug 2020

Reply Repost Favourite

Important Health Notice: Low carb diets are not recommended for people with type 2 diabetes because they raise LDL-C. "The mechanism that an SGLT2 inhibitor increases LDL-C levels remains unknown..." https://t.co/VKjpiKChER

24 Feb 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.